Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell wall and membrane macromolecules of Cutibacterium acnes and related species, such as Cutibacterium granulosum and Staphylococcus epidermidis, are essential structural components that maintain cellular integrity and mediate host-pathogen interactions (StatPearls, 2023). These macromolecules, including peptidoglycan, neutral polysaccharides, and lipoglycans, serve as pathogen-associated molecular patterns (PAMPs) that trigger the innate immune response via Toll-like receptor 2 (TLR2) on host keratinocytes and macrophages (PubMed, PMID: 12117824). This activation leads to the secretion of pro-inflammatory cytokines like IL-8 and IL-12, which are central to the development of inflammatory acne lesions (NIH, 2022). Therapeutic agents such as benzoyl peroxide target these structures by generating reactive oxygen species that cause non-specific oxidative damage to the bacterial membrane and wall (PubChem, CID: 2334). Azelaic acid further disrupts the bacterial envelope by interfering with transmembrane pH gradients and protein synthesis (PubMed, PMID: 2534550). Understanding these targets is crucial for managing acne and preventing systemic infections associated with C. acnes, such as those involving prosthetic implants (PubMed, PMID: 30124144).
The primary mechanism of action for drugs targeting these macromolecules involves the induction of oxidative stress, which leads to the non-specific destruction of bacterial membrane lipids and wall proteins. Other agents disrupt the transmembrane electrochemical gradient or inhibit the synthesis of essential cellular components required for envelope maintenance.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell wall and membrane macromolecules of Cutibacterium acnes and related acne-associated bacteria.